Maculopapular drug eruptions

Drug Hypersensitivity

Volumn , Issue , 2007, Pages 242-250

  Yawalkar Dr , Nikhil ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67349109007     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000104204     Document Type: Chapter

References (29)

1. Bigby M, Jick S, Jick H, Arndt K: Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 con-secutive inpatients, 1975-1982. JAMA 1986;256:3358-3363.
2. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R: Comprehensive hospital drug monitoring: adverse skin reactions, a 20-year survey. Allergy 1997;52:388-393.
3. Crowson AN, Brown TJ, Magro CM: Progress in the understanding of the pathology and pathogenesis of cutane-ous drug eruptions: implications for management. Am J Clin Dermatol 2003;4:407-428.
4. Apaydin R, Bilen N, Dokmeci S, Bayramgurler D, Yildirim G: Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. J Eur Acad Dermatol Venereol 2000;14:518-520.
5. Bigby M: Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765-770.
6. Nigen S, Knowles SR, Shear NH: Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2003;2:278-299.
7. Gomes ER, Demoly P: Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-316.
8. Lerch M, Pichler WJ: The immunologi-cal and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004;4:411-419.
9. Hertl M, Merk HF: Lymphocyte activa-tion in cutaneous drug reactions. J In-vest Dermatol 1995;105:95-98.
10. Yawalkar N, Pichler WJ: Immunohis-tology of drug-induced exanthema: clues to pathogenesis. Curr Opin Al-lergy Clin Immunol 2001;1:299-303.
11. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Infiltra-tion of cytotoxic T cells in drug-in-duced cutaneous eruptions. Clin Exp Allergy 2000,30:847-855.
12. Blanca M, Posadas S, Torres MJ, Leyva L, Mayorga C, Gonzalez L, Juarez C, Fernandez J, Santamaria LF: Expres-sion of the skin-homing receptor in peripheral blood lymphocytes from subjects with non-immediate cutane-ous allergic drug reactions. Allergy 2000;55:998-1004.
13. Barbaud AM, Bene MC, Schmutz JL, Ehlinger A, Weber M, Faure GC: Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes. Arch Dermatol 1997;133:481-486.
14. Posadas SJ, Torres MJ, Mayorga C, Juarez C, Blanca M: Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol Dis 2002;29:179-189.
15. Schnyder B, Frutig K, Mauri-Hellweg D, Limat A, Yawalkar N, Pichler WJ: T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction. Clin Exp Allergy 1998;28:1412-1417.
16. Yawalkar N: Drug-induced examthems. Toxicology 2005;209:131-134.
17. Pichler W, Yawalkar N, Schmid S, Helbling A: Pathogenesis of drug-in-duced exanthems. Allergy 2002;57:884-893.
18. Hertl M, Bohlen H, Jugert F, Boecker C, Knaup R, Merk, HF: Predominance of epidermal CD8+ T lymphocytes in bul-lous cutaneous reactions caused by β lactam antibiotics. J Invest Dermatol 1993;101:794-799.
19. Yawalkar N, Shrikhande M, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000;106:1171-1176.
20. Posadas SJ, Leyva L, Torres MJ, Rodri-guez JL, Bravo I, Rosal M, Fernandez J, Juarez C, Blanca M: Subjects with aller-gic reactions to drugs show in vivo po-larized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immu-nol 2000;106:769-776.
21. Tapia B, Padial A, Sanchez-Sabate E, Alvarez-Ferreira J, Morel E, Blanca M, Bellon T: Involvement of CCL27-CCR10 interactions in drug-induced cutane-ous reactions. J Allergy Clin Immunol 2004;114:335-340.
22. Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994 10;331:1272-1285.
23. Bronnimann M, Yawalkar N: Histopa-thology of drug-induced exanthems: Is there a role in diagnosis of drug aller-gy? Curr Opin Allergy Clin Immunol 2005;5:317-321.
24. Fellner MJ, Prutkin L: Morbilliform eruptions caused by penicillin. A study by electron microscopy and immuno-logic tests. J Invest Dermatol 1970;55:390-395.
25. Barbaud A: Drug patch testing in sys-temic cutaneous drug allergy. Toxicol-ogy 2005;209:209-216.
26. Hug K, Yawalkar N, Helbling A, Pichler WJ: Scratch-patch and patch testing in drug allergy -an assessment of speci-ficity. J Investig Allergol Clin Immunol 2003;13:12-19.
27. Lammintausta K, Kortekangas-Savolainen O: The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005;152:968-974.
28. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-820.
29. Belchi-Hernandez J, Espinosa-Parra FJ: Management of adverse reactions to prophylactic trimethoprim-sulfa-methoxazole in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 1996;76:355-358.